TY - JOUR T1 - Dimethyl fumarate for COVID-19 JF - BMJ Supportive & Palliative Care JO - BMJ Support Palliat Care DO - 10.1136/bmjspcare-2021-003250 SP - bmjspcare-2021-003250 AU - Yashdeep Singh Pathania Y1 - 2021/06/25 UR - http://spcare.bmj.com/content/early/2021/06/25/bmjspcare-2021-003250.abstract N2 - To the editor,The menace of COVID-19 pandemic has entered into the second year, and still it is expanding, evading every possible medical therapy being offered. There has been no specific antiviral therapy for SARS CoV-2 discovered to date. It has been found that COVID-19 induces immune dysregulation, hyperinflammation and oxidative stress (cytokine storm), which leads to patient morbidity and even mortality. The alleviation of cytokine storm is a logical approach to decrease the mortality. Dexamethasone (corticosteroid) has been successfully used in the treatment of COVID-19.1 Dimethyl fumarate (DMF) has comparable immunosuppressive properties like corticosteroids and has shown effectiveness in COVID-19. … ER -